摘要 |
Isolated peptides comprising an amino acid sequence having Formula I <?in-line-formulae description="In-line Formulae" end="lead"?>X1X2X3X4, I<?in-line-formulae description="In-line Formulae" end="tail"?> wherein X1 is an optional residue of an amino acid selected from the group of R, F, Y, S and conservative substitutes thereof; X2 stands for a residue of an amino acid selected from the group of R and A and conservative substitutes thereof; X3 is a residue of an amino acid selected from the group of F, P, G, Q, M and conservative substitutes thereof; and X4 is a residue of an amino acid selected from the group of K, F, G, P and conservative substitutes thereof. The novel peptides are capable of binding to human kallikrein 2 and of inhibiting the proteolytic activity of human kallikrein 2. They can be used in prostate cancer treatment as such or in combination with other ligands modulating the activity of factors mediating tumor growth.
|